Блог

5 Ways to Keep Your Stem Cells Healthy: What 2026 Science Says

Your body's repair system ages with you — but exercise, sleep, fasting, diet, and stress management all have measurable effects on stem cell function. Here is what the latest research says.

Oct 19, 2026

MSC Therapy for Atopic Dermatitis: Meta-Analysis of RCTs and Phase 2 Data Reveal

A 2026 meta-analysis pools 236 patients across 5 trials, and a 114-patient Phase 2 RCT shows MSC therapy achieves EASI-75 in 24% of severe AD patients. Exosome hydrogel delivery and batch consistency data now address the…

Oct 18, 2026

Stem Cell Therapy for Low Back Pain: What the 2025–2026 Clinical Trials Actually Show

Three major clinical trials — including a 404-patient 3-year study — are finally giving us real data on whether MSC therapy works for chronic low back pain and degenerative disc disease. Here's what the evidence says, in…

Oct 17, 2026

MSC Therapy for Parkinson’s Disease: What Randomized Trials and Comprehensive Reviews Reveal

Multiple 2026 clinical trials and reviews show mesenchymal stem cell therapy is safe and feasible for Parkinson's disease — but what do the actual data say about efficacy, dosing, and what comes next?

Oct 16, 2026

MSC Therapy for Pediatric Acute GvHD: From FDA Approval to Next-Generation Approaches

The first FDA-approved MSC therapy (Ryoncil) ended a 20-year drought for cell-based products in the US. New real-world data from 139 children and next-generation platforms are reshaping how clinicians treat steroid-refra…

Oct 15, 2026

Can Stem Cell Therapy Help Children with Autism? What 2026 Research Shows

A double-blind RCT shows cord blood stem cells improved social cognition in children with autism. Here's what parents need to know about the latest research, safety data, and treatment process.

Oct 14, 2026

MSC Therapy for Chronic Kidney Disease: What the 2025 Evidence Shows

A 2025 meta-analysis of 52 studies, real-world Taiwan data, and Mayo Clinic intraarterial delivery results — what nephrologists need to know about MSCs and CKD.

Oct 14, 2026

MSC Therapy for Pulmonary Fibrosis: 2026 Preclinical and Clinical Evidence Review

A medical review of MSC-based and MSC-derived EV therapies for idiopathic pulmonary fibrosis, covering meta-analysis data, immune-cloaked cell engineering, nebulized exosome delivery, gut-lung axis mechanisms, and active…

Sep 23, 2026

MSC Therapy for Ischemic Stroke: What a 2026 Umbrella Review and Network Meta-Analysis of 1,006 Patients Reveal

The 2026 evidence base for mesenchymal stem cell therapy in ischemic stroke includes a 26-study umbrella review and an 18-RCT network meta-analysis of 1,006 patients. MSCs were the only cell type to significantly reduce …

Sep 7, 2026

Почему активность стволовых клеток замедляется после 40 лет (и что делает наука для решения этой проблемы)

Research shows MSC activity drops 40% by age 50. Learn what changes inside aging cells and three emerging therapies showing real results in 2026 clinical trials.

Sep 4, 2026

Клинические испытания МСК: что ISCT Dublin рассказал о восстановлении мениска, переносе митохондрий и источниках клеток.

Медицинский обзор клинических испытаний МСК 2026 года: ключевые данные из ISCT Dublin, японского исследования III фазы по восстановлению мениска с помощью синовиальных МСК, данные по остеоартрозу, полученным при сравнении костного мозга и пуповинной ткани, а также механизмы действия митохондриальных внеклеточных везикул.

Aug 28, 2026

Дышать легче: как терапия стволовыми клетками меняет лечение ХОБЛ в Таиланде

В нашей клинике в Бангкоке изучают, как терапия с использованием мезенхимальных стволовых клеток помогает пациентам с ХОБЛ легче дышать — уменьшая воспаление, активируя стволовые клетки легких и улучшая качество жизни.

Aug 28, 2026

Page 1 of 13 — 156 posts